Hertil kommer, at der i kliniske undersøgelser er observeret bivirkninger med en hyppighed på under 1%, som af forskerne blev bedømt som værende vaccine - eller placeborelaterede,:
In addition, in clinical trials adverse reactions that were judged to be vaccine- or placebo-related by the study investigator were observed at frequencies lower than 1%: